Pflug Koory’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $85.1K | Hold |
464
| – | – | 0.04% | 196 |
|
|
2025
Q4 | $81.7K | Hold |
464
| – | – | 0.04% | 196 |
|
|
2025
Q3 | $65K | Buy |
464
+250
| +117% | +$33.8K | 0.03% | 215 |
|
|
2025
Q2 | $26.9K | Hold |
214
| – | – | 0.01% | 266 |
|
|
2025
Q1 | $29.3K | Hold |
214
| – | – | 0.02% | 253 |
|
|
2024
Q4 | $32.7K | Sell |
214
-40
| -16% | -$6.75K | 0.02% | 256 |
|
|
2024
Q3 | $49.2K | Buy |
+254
| New | +$53.1K | 0.02% | 230 |
|
|
2024
Q1 | $51.3K | Hold |
238
| – | – | 0.03% | 223 |
|
|
2023
Q4 | $61.6K | Buy |
238
+55
| +30% | +$13.5K | 0.03% | 217 |
|
|
2023
Q3 | $47K | Buy |
183
+23
| +14% | +$6.15K | 0.03% | 221 |
|
|
2023
Q2 | $45.6K | Hold |
160
| – | – | 0.02% | 234 |
|
|
2023
Q1 | $44.5K | Hold |
160
| – | – | 0.02% | 238 |
|
|
2022
Q4 | $44K | Hold |
160
| – | – | 0.02% | 239 |
|
|
2022
Q3 | $43K | Hold |
160
| – | – | 0.03% | 241 |
|
|
2022
Q2 | $33K | Hold |
160
| – | – | 0.02% | 268 |
|
|
2022
Q1 | $34K | Buy |
160
+75
| +88% | +$16.3K | 0.02% | 282 |
|
|
2021
Q4 | $20K | Buy |
85
+28
| +49% | +$7.2K | 0.01% | 320 |
|
|
2021
Q3 | $16K | Hold |
57
| – | – | 0.01% | 329 |
|
|
2021
Q2 | $20K | Hold |
57
| – | – | 0.01% | 313 |
|
|
2021
Q1 | $16K | Hold |
57
| – | – | 0.01% | 336 |
|
|
2020
Q4 | $14K | Buy |
57
+10
| +21% | +$2.58K | 0.01% | 322 |
|
|
2020
Q3 | $13K | Hold |
47
| – | – | 0.01% | 298 |
|
|
2020
Q2 | $13K | Hold |
47
| – | – | 0.01% | 297 |
|
|
2020
Q1 | $15K | Hold |
47
| – | – | 0.01% | 272 |
|
|
2019
Q4 | $14K | Buy |
47
+10
| +27% | +$2.77K | 0.01% | 305 |
|
|
2019
Q3 | $9K | Hold |
37
| – | – | 0.01% | 334 |
|
|
2019
Q2 | $9K | Hold |
37
| – | – | 0.01% | 326 |
|
|
2019
Q1 | $9K | Hold |
37
| – | – | 0.01% | 340 |
|
|
2018
Q4 | $11K | Hold |
37
| – | – | 0.01% | 307 |
|
|
2018
Q3 | $13K | Hold |
37
| – | – | 0.01% | 310 |
|
|
2018
Q2 | $11K | Buy |
37
+12
| +48% | +$3.37K | 0.01% | 315 |
|
|
2018
Q1 | $7K | Hold |
25
| – | – | 0.01% | 333 |
|
|
2017
Q4 | $8K | Hold |
25
| – | – | 0.01% | 319 |
|
|
2017
Q3 | $8K | Hold |
25
| – | – | 0.01% | 325 |
|
|
2017
Q2 | $7K | Hold |
25
| – | – | 0.01% | 325 |
|
|
2017
Q1 | $7K | Buy |
+25
| New | +$7.07K | 0.01% | 321 |
|
Other funds holding BIIB
VCM
VPM
Pflug Koory's BIIB Position: Q1 2026 in Review
Pflug Koory held its Biogen (BIIB) position steady in Q1 2026 at 464 shares worth $85.1K. The position accounts for 0.04% of the portfolio, ranked #196.
Pflug Koory first reported a position in BIIB in Q1 2017 and has held it in 36 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Pflug Koory held 464 shares of Biogen worth $85.1K as of Q1 2026.
- Pflug Koory left its Biogen share count unchanged in Q1 2026.
- Biogen made up 0.04% of Pflug Koory's portfolio in Q1 2026, its #196 holding.
- Pflug Koory first reported a position in Biogen in Q1 2017 and has held it in 36 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Pflug Koory's 13F filing for Q1 2026, filed 22 Apr 2026.